Colgate-Palmolive (NYSE:CL) Receives $93.83 Average Target Price from Brokerages

Shares of Colgate-Palmolive (NYSE:CLGet Free Report) have received an average rating of “Moderate Buy” from the seventeen analysts that are presently covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $93.83.

A number of research firms recently issued reports on CL. Royal Bank of Canada upped their price objective on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a research report on Monday, April 29th. The Goldman Sachs Group assumed coverage on Colgate-Palmolive in a report on Friday, March 1st. They set a “buy” rating and a $93.00 price objective on the stock. Barclays upped their target price on Colgate-Palmolive from $84.00 to $85.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 30th. Argus lifted their price target on Colgate-Palmolive from $97.00 to $107.00 and gave the company a “buy” rating in a research note on Wednesday, May 15th. Finally, Wells Fargo & Company raised their price objective on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the company an “equal weight” rating in a report on Monday, April 29th.

Read Our Latest Analysis on Colgate-Palmolive

Insider Buying and Selling at Colgate-Palmolive

In related news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $94.06, for a total value of $1,149,977.56. Following the sale, the insider now directly owns 13,924 shares in the company, valued at approximately $1,309,691.44. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Colgate-Palmolive news, insider Sally Massey sold 12,226 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the sale, the insider now owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider John W. Kooyman sold 3,497 shares of the firm’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $93.47, for a total value of $326,864.59. Following the completion of the transaction, the insider now directly owns 3,181 shares of the company’s stock, valued at $297,328.07. The disclosure for this sale can be found here. 0.34% of the stock is owned by corporate insiders.

Institutional Trading of Colgate-Palmolive

A number of large investors have recently modified their holdings of the business. Legacy Trust raised its stake in Colgate-Palmolive by 1.7% during the 1st quarter. Legacy Trust now owns 6,925 shares of the company’s stock valued at $624,000 after buying an additional 116 shares during the last quarter. Checchi Capital Advisers LLC increased its position in Colgate-Palmolive by 1.5% during the first quarter. Checchi Capital Advisers LLC now owns 7,829 shares of the company’s stock valued at $705,000 after acquiring an additional 118 shares during the last quarter. Regal Investment Advisors LLC lifted its holdings in Colgate-Palmolive by 1.6% in the fourth quarter. Regal Investment Advisors LLC now owns 7,574 shares of the company’s stock valued at $604,000 after acquiring an additional 121 shares during the period. M&G Investment Management Ltd. boosted its position in Colgate-Palmolive by 0.3% in the fourth quarter. M&G Investment Management Ltd. now owns 49,269 shares of the company’s stock worth $3,942,000 after purchasing an additional 125 shares during the last quarter. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors grew its stake in shares of Colgate-Palmolive by 3.8% during the 1st quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors now owns 3,374 shares of the company’s stock valued at $304,000 after purchasing an additional 125 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 1.2 %

Colgate-Palmolive stock opened at $96.99 on Wednesday. The stock has a market capitalization of $79.57 billion, a P/E ratio of 30.69, a PEG ratio of 3.62 and a beta of 0.39. The stock has a 50-day simple moving average of $93.87 and a 200 day simple moving average of $87.51. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $99.08. The company has a debt-to-equity ratio of 13.21, a quick ratio of 0.70 and a current ratio of 1.06.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. The company had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. Colgate-Palmolive’s quarterly revenue was up 6.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.73 earnings per share. Analysts expect that Colgate-Palmolive will post 3.53 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, July 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.06%. Colgate-Palmolive’s payout ratio is currently 63.29%.

Colgate-Palmolive Company Profile

(Get Free Report

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.